Mizuho Securities Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $105
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $108
Encompass Health Analyst Ratings
KeyBanc Initiates Encompass Health at Overweight With $115 Price Target
RBC Capital Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $105
Encompass Health Is Maintained at Buy by UBS
Encompass Health Analyst Ratings
UBS Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $110
Encompass Health Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Encompass Health (EHC) and Ardent Health Partners, Inc. (ARDT)
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $104
UBS Adjusts Encompass Health Price Target to $100 From $96, Maintains Buy Rating
Jefferies Reaffirms Their Buy Rating on Encompass Health (EHC)
Analysts' Top Healthcare Picks: Encompass Health (EHC), Castle Biosciences (CSTL)
Buy Rating Affirmed for Encompass Health on Strong Q2 Performance and Raised Guidance
Stephens & Co. Reiterates Overweight on Encompass Health, Maintains $105 Price Target
Encompass Health Analyst Ratings
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating
Barclays Maintains Encompass Health(EHC.US) With Buy Rating, Cuts Target Price to $109
Barclays Keeps Their Buy Rating on Encompass Health (EHC)